KRMN is caught in an uncomfortable post-earnings hangover — the Q1 relief bounce has already faded, the Street is trimming numbers, and shorts are not backing down.
The stock closed at $64.20 on Tuesday, down 3% on the day but up about 2.8% on the week — a week that included a fresh round of analyst target cuts. That price action tells the whole story: each bounce is being sold, and the gap between where the stock trades and where analysts think it should trade remains wide. The mean price target has pulled back to $105.60, implying roughly 65% upside from current levels. That kind of gap usually signals either a deeply misunderstood stock or one where the Street's estimates are still catching up to reality.
Short interest has continued to grind higher since last week's note. At 7.2% of the free float — now just over 9.5 million shares — the short position has grown 15% over the past month and nearly 3% in the past week alone. That is a sustained build, not a one-day spike. Days to cover is running above five sessions per official FINRA data, which makes any rapid short-covering scenario harder to execute. The borrow market, however, still has room. Availability is running at roughly 167% of current short interest — meaning there are nearly 57 million shares available to lend against the 9.5 million already borrowed. That is a tight range relative to the 52-week availability floor of 73%, but it remains well above a squeeze-pressure level. Cost to borrow has jumped — nearly doubling over the week to just over 1% — which is notable directionally, though still modest in absolute terms. The combination of rising shorts, tightening availability, and accelerating borrow costs points to a lending market that is incrementally more contested this week than last.
Options positioning is tipping cautious. The put/call ratio edged up to 1.03, slightly above its 20-day average of 0.95 — not an extreme reading, but above the recent midline and at roughly one standard deviation elevated. It is a mild signal that options traders are adding a layer of downside protection rather than positioning aggressively for a bounce.
The Street's direction of travel is clear: firms are holding their ratings but cutting their numbers. Keybanc trimmed its target from $122 to $100 while keeping Overweight. Piper Sandler moved from $127 to $114, also maintaining Overweight. Citigroup cut from $127 to $97 on a Buy. Evercore ISI had already moved from $125 to $100 the week before. BWS Financial remains an outlier bear, holding a $37 Sell target unchanged. The bull case rests on backlog growth, hypersonic weapons exposure, and the $1B-plus contingent commitment announced at Q1. The bear case centres on execution risk in a fragmented supply chain, margin pressure in a growth-heavy model, and defence budget uncertainty. The EV/EBITDA multiple has compressed about 5% over the past month to 38x, and the P/E sits near 91x — still elevated, with the factor scores flagging deep-value weakness (EV/EBIT in the fourth percentile of the universe) and soft EPS momentum at both 30- and 90-day horizons.
One ownership note worth flagging: Trive Capital Management entered as a brand-new holder in Q1, taking a 2.97% stake — the entire position was built from scratch in the quarter. At the same time, Capital Research trimmed by over 1.1 million shares. Institutional conviction on KRMN appears split, with new money coming in at the same time established holders are rotating out. The insider ledger remains stale — the most recent reported trades date to December 2025, all sales by C-suite executives in the $58–$69 range, which brackets the current price closely.
The ORTEX short score held at 62.7, little changed over the week, suggesting that the aggregate pressure signal has stabilised rather than escalated — but it has not eased either. With the next earnings event not until August 11, the near-term focus shifts entirely to whether the wave of target reductions is finished or whether further estimate revisions are still working through the system.
See the live data behind this article on ORTEX.
Open KRMN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
